Sun Pharma Announces Phase 2 Clinical Trial Results for SCD-044 in Psoriasis and Atopic Dermatitis
365Telugu.com online news,India,June 4th, 2025:Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA, BSE: 524715), along with its subsidiaries and associated